Author:
Gina Folk, MLS(ASCP)CMSBBCM, MSHS
Immunohematology Reference Laboratory
Community Blood Center of Kansas City
Kansas City, Missouri
Lynsi Rahorst, MHPE, MT(ASCP)SBBCM
Immunohematology Reference Laboratory/Genomics
New York Blood Center Enterprise
Kansas City, Missouri
Primary Audience:
Phlebotomists, Laboratory Technologists, Laboratory Directors
Secondary Audience:
Pathologists, Clinical Scientists (Includes all sub-specialty areas), Students, Pathologist Assistants, Residents, and Students
Upon completion of this activity, you will be able to:
· discuss fetal/neonatal alloimmune thrombocytopenia (FNAIT), including symptoms, prevalence, and etiology;
· describe laboratory testing that aids in the diagnosis of FNAIT;
· interpret results of laboratory testing for FNAIT;
· identify common treatments for a neonate with FNAIT;
· discuss prenatal management options for pregnancies at risk for FNAIT; and
· summarize the challenges associated with screening pregnancies to identify those at risk for FNAIT.